Prescription drug · NDA
Cortifoam (Hydrocortisone acetate) NDC 0037-6830
Hydrocortisone acetate 1500 mg/15g · Aerosol, Foam · Topical · Viatris Specialty LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0037-6830-15 | 00037683015 | 1 CANISTER in 1 CARTON (0037-6830-15) / 15 g in 1 CANISTERMarketed from Jun 15, 2015 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cortifoam
- Generic name (nonproprietary)
- hydrocortisone acetate
- Active ingredients
- Hydrocortisone acetate — 1500 mg/15g
- Dosage form
- Aerosol, Foam
- Route
- Topical
- Labeler
- Viatris Specialty LLCNDC labeler code 0037
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 017351
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 0037-6830_c53f12f0-249b-4462-b669-b9ae2b626051SPL ID c53f12f0-249b-4462-b669-b9ae2b626051SPL set ID 0093b694-9fcb-46ae-b1ab-7d0fa204c6c8RxCUI 1545172, 1545174UNII 3X7931PO74
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400037683015followed by a unit qualifier and the quantityPackage 00037-6830-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Cortifoam ® is indicated as adjunctive therapy in the topical treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas.
Excerpt only. Read the full label for complete information.
About NDC 0037-6830
- What is NDC 0037-6830?
- 0037-6830 is the product NDC for Cortifoam (hydrocortisone acetate), Hydrocortisone acetate 1500 mg/15g aerosol, foam, listed with the FDA by Viatris Specialty LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cortifoam (Hydrocortisone acetate).
- What is the active ingredient?
- Hydrocortisone acetate.
- Who is the labeler?
- Viatris Specialty LLC, NDC labeler code 0037. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cortifoam?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.